Junshi Biosciences funding history / development milestones

IPO上市,

2020.07.15,上交所

Note: collected from public online reports, for reference only.

People who follow Junshi Biosciences also follow

Junshi Biosciences Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“Continuously innovating to bring patients medicines that significantly”
“To develop high-quality biologics that are accessible and affordable f”
生物科技/生物工程 蛋白质工程 药物研发 生物制药
“Focused on three major fields: healthcare, life science, and electroni”
“In the rapidly growing biopharmaceutical field, accelerate and transfo”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Promoting human health”
“Dedicated to the research and development of molecularly targeted drug”
“Global integrated biopharmaceutical enterprise”
“An innovative biopharmaceutical enterprise focusing on antibody drugs”
制药/药业 抗肿瘤药 肿瘤检测 神经系统疾病药物
“Provides consulting and services to over one hundred pharmaceutical ma”
“A provider of overall products, solutions, and services in the medical”
“Technological innovation and commercial application of pharmaceutical ”